课题基金 / 基金详情

ACTG356--ZDV/3TC/NEVIRAPINE &ZDV/3TC/NEVIRAPINE/159U89 COMBINATION THERAPY

ACTG356--ZDV/3TC/NEVIRAPINE &ZDV/3TC/NEVIRAPINE/159U89 COMBINATION THERAPY
ACTG356--ZDV/3TC/奈韦拉平
批准号:
6309010
负责人:
Kenneth McIntosh
金额:
$2.88万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-12-01 至 2000-11-30

项目摘要

项目成果

Kenneth McIntosh的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Phase I/II trial of three reverse taranscriptase inhibitors in the treatment of very young, vertically HIV-infected infants, with the aim of suppressing viral production maximally at a time very shortly after infection, or as soon as practically possible. There are two cohorts, but in both instances, it can be expected that the child's virus will be oligoclonal and the level of production will be very high (RNA viral loads of 5-6 logs/ml).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PACTG 1038: HIGH DOSE LOPINAVIR/RITONAVIR W/ OR W/OUT SAQUINAVIR IN HIV
  • 批准号:
    7607270
  • 项目类别:
  • 资助金额:
    $1.3万
  • 财政年份:
    2007
  • 负责人:
    Kenneth McIntosh
  • 依托单位:
PACTG 1038:PHASE I/II HIGH DOSE LOPINAVIR/RITONAVIR WITH OR WITHOUT SAQUINAVIR I
  • 批准号:
    7380759
  • 项目类别:
  • 资助金额:
    $13.6万
  • 财政年份:
    2006
  • 负责人:
    Kenneth McIntosh
  • 依托单位:
A COLLABORATIVE STUDY OF VERTICAL TRANSMISSION OF HIV (WITS IV)
  • 批准号:
    6975158
  • 项目类别:
  • 资助金额:
    $0.04万
  • 财政年份:
    2004
  • 负责人:
    Kenneth McIntosh
  • 依托单位:
PACTG-1024 Eval. of the Immunogenicity of pneumococcal conjugate vaccine & rout.
  • 批准号:
    6975147
  • 项目类别:
  • 资助金额:
    $0.21万
  • 财政年份:
    2004
  • 负责人:
    Kenneth McIntosh
  • 依托单位:
海外基金